Skip to main content

Table 1 Patients characteristics

From: Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy

Characteristics

Total cohort (%)

Radical prostatectomy (%)

Patients

274 (100)

90 (100)

Age (years)

66.8 ± 8.1

60.9 ± 6.8

PSA (ng/mL)

 <10

179 (65.3)

68 (75.6)

 10–20

66 (24.1)

18 (20.0)

 >20

29 (10.6)

4 (4.4)

Gleason score

  

 ≤6

137 (50.0)

60 (66.7)

 7

108 (39.4)

24 (26.7)

 ≥8

29 (10,6)

6 (6.6)

cT-category before mpMRI

 ≤T2a

239 (87.2)

84 (93.3)

 T2b–T2c

30 (11.0)

6 (6.7)

 T3a

5 (1.8)

0

 T3b

0

0

 T4

0

0

Risk groups

  

 Low

95 (34.7)

43 (47.8)

 Intermediate

127 (46.4)

37 (41.1)

 High

52 (19.0)

10 (11.1)

Positive prostate biopsies

  

 <50 %

158 (57.7)

49 (54.4)

 ≥50 %

65 (23.7)

16 (17.8)

 (Non classified)

51 (18.6)

25 (27.8)

  1. mpMRI multiparametric magnetic resonance imaging, PSA prostate-specific antigen